|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's Range||48.34 - 52.54|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||107.67|
It wasn't very difficult for Greenlane Holdings to become the best IPO ever for a U.S. marijuana stock on the Nasdaq. Here's why.
Canopy Growth's Acreage Acquisition Boosts Sentiment(Continued from Prior Part)ACB, IIPR, and OGI gain On April 18, in the first half of the trading session, Aurora Cannabis (ACB) was trading up 1% while Innovative Industrial Properties (IIPR)
Canopy Growth to Acquire Acreage Holdings(Continued from Prior Part)Canopy Growth jumps Canopy Growth (WEED) (CGC) announced that it will acquire Acreage Holdings for a total value of $3.4 billion, which led the company’s stock price to jump on
Canopy Growth will probably purchase the rights to buy Acreage Holdings to tap the growing potential of the U.S. marijuana market. This should bolster the ETF MJ.
Canopy Growth to Acquire Acreage HoldingsCanopy Growth to Acquire Acreage Holdings On April 18, Canopy Growth (WEED) (CGC) announced that it entered an agreement to acquire Acreage Holdings. Acreage Holdings has a presence in 20 states in the US
Predominantly, most countries which have adopted cannabis legislation have legalized the plant specifically for medical purposes. Countries such as Argentina, Chile, Colombia, and Brazil have all legalized medical cannabis, while some have also decriminalized cannabis, allowing for moderate personal consumption. In combination, all of these factors are further accelerating the Latin American cannabis industry by inviting new business opportunities.
Cannabis producers and sellers are scrambling to secure product and cultivation space as the substance goes mainstream in Canada and parts of the U.S. The common thinking is that demand for high-quality products will exceed supply for some time as more regions legalize medically and recreationally. Production potential is key, and one emerging company, Item 9 Labs, plans to quadruple their production by the end of this year, and they're planning to enter new markets through licensing and permitting in the next 12 months as well. NEW YORK, NY / ACCESSWIRE / April 18, 2019 / It may feel slow-going, but U.S. states are slowly coming around on medical marijuana use.
CGC, HEXO, CTST Moving Higher Today(Continued from Prior Part)Tilray mutedOn April 17, Tilray (TLRY) remained muted, with the stock almost flat as of noon. The stock remained depressed as the overall cannabis industry has slumped in April.
BofA Merrill Lynch Initiated Coverage on Canopy Growth(Continued from Prior Part)Analysts’ ratings Early on April 17, Bank of America Merrill Lynch initiated coverage on three cannabis stocks. Aurora Cannabis (ACB) received a “buy”
DENVER, April 17, 2019 /CNW/ -- Ever since the Farm Bill was signed into law, farmers across the United States have rushed into hemp cultivation, driving demand for the supplies needed to grow the crop necessary to meet surging CBD use. Global hemp industry to reach $22 billion in 2022. Hemp is booming across the country, and nowhere more so than in Kentucky, where the applications to grow hemp are expected to increase fivefold, and acreage dedicated to growing the crop is set to more than triple this year.
Irwin Simon Says Aphria Will Hit 1 Billion in Sales by 2020(Continued from Prior Part)Analyst ratings The consensus analyst rating on Aphria (APHA) after its earnings were released remained unchanged compared to the previous month. As the chart
Irwin Simon Says Aphria Will Hit 1 Billion in Sales by 2020Aphria’s earnings Earlier this week, Aphria (APHA) reported its Q3 earnings. During the earnings call, the company’s interim CEO, Irwin Simon, was very optimistic about the company’s
Canopy Growth Continues to Expand amid Market Weakness(Continued from Prior Part)Acquiring CafinaEarly today, Canopy Growth (WEED) (CGC) announced it had acquired Spanish company Cafina, through which Canopy intends to establish a broader reach in
TLRY, CGC, ACB Snap Out of Their Losing StreaksCannabis sector gains Today, overall cannabis sector sentiment appeared to improve with the Horizons Marijuana Life Sciences ETF (HMMJ) gaining 1.7% while the ETFMG Alternative Harvest ETF (MJ) gained
Canopy Growth Continues to Expand amid Market WeaknessMarket weaknessThe cannabis sector has weakened recently. Most cannabis stocks ended March in negative territory, and this trend has worsened in April. Tilray (TLRY) and CannTrust (CTST) have
HOUSTON, TX / ACCESSWIRE / April 16, 2019 / Patent applications from cannabis companies offer a look into the battle to secure intellectual properties in the U.S. The patent application can be used as a basis for obtaining patent protection in over 170 countries, including the US, Canada, the UK, France, Germany, Russia, China, Brazil, Japan, and Australia.
OrganiGram: Key Takeaways from Its Q2 Earnings(Continued from Prior Part)Analysts’ views OrganiGram (OGRMF) reported its second-quarter earnings on April 15. The company’s top line increased more than 690%. However, the company reported a
OrganiGram: Key Takeaways from Its Q2 EarningsOrganiGram’s second-quarter earningsOn April 15, OrganiGram (OGRMF) reported its second-quarter earnings with net revenues of 26.9 million Canadian dollars. The revenues grew ~693% from 3.4 million
Aphria Declines, Other Cannabis Stocks FollowAphria fellEarly on April 15, Aphria (APHA) released its third-quarter earnings, which missed the expectations. The company’s losses widened to 108 million Canadian dollars due to a write-off
Aphria Reported Its Q3 Earnings, Stock Fell(Continued from Prior Part)Aphria swings to lossesEarly on April 15, Aphria (APHA) reported its third-quarter earnings. The company had quarterly losses of ~108 million Canadian dollars. The losses were
Aphria Reported Its Q3 Earnings, Stock FellAphria’s earnings Early on April 15, Aphria (APHA) reported its third-quarter financial results. The company reported revenues of 73.6 million Canadian dollars, which grew ~617% year-over-year and ~240%
NEW YORK, April 15, 2019 /CNW/ -- Recent moves by both New Jersey and Pennsylvania towards marijuana legalization are pushing expectations on US stocks ahead of their neighbors to the North. The result has been a recent increased focus on US-based companies such as Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF - News), Planet 13 Holdings Inc. (CSE:PLTH) (OTC:PLNHF - News), KushCo Holdings, Inc. (OTC:KSHB - News), Charlotte's Web Holdings, Inc. (OTC:CWBHF - News) (CSE:CWEB) and Tilray, Inc. (NASDAQ:TLRY - News). The move further expanded the company's reach to three states, with the first two being Washington and California.